Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...
Prostate cancer is the second leading cause of cancer among men, according to the Centers for Disease Control and Prevention ...
Zydus Lifesciences has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture ...
The Rochester, Minnesota-based Mayo Clinic, which also has locations in Arizona and Jacksonville, Florida, has been expanding ...
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...
October 02, 2024--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced that new data from the multicenter, prospective VANDAAM trial show that the Decipher ...
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients ...
The pink and blue fire truck is meant to promote early screening for breast and prostate cancers. Pro Style Wraps provided ...
As autumn leaves begin to paint the D.C., Maryland, and Virginia region in warm hues, a kaleidoscope of cultural events is ...
For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who ...
The Seahawks partnered with Virginia Mason Franciscan Health for the NFL's Crucial Catch initiative. In honor of the ...
The 16th annual Pros4Care golf benefit drew 75 attendees and raised about $10,000 to fund prostate cancer research and ...